Add to My Stocks
$19.74 $0.3 (1.5%) APNHY stock closing price Jun 15, 2018 (Closing)

The ASPEN PHARMACR cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows ASPEN PHARMACR profits, the balance sheet shows ASPEN PHARMACR debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. ASPEN PHARMACR saw a cash impact of $- from the buyback of APNHY shares. The cash flow statement helps in the ASPEN PHARMACR stock analysis by providing more information for evaluating changes in assets, liabilities and equities. The cash from operating activities for ASPEN PHARMACR is $ 2017, which saw an increase from previous year.

View details of ASPEN PHARMACR cash flows for latest & last 10 financial years
show more
Fiscal year is Jul - Jun20172016
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow95.55M83.28M
Net Increase (Decrease) in Assets Liabilities-66.14M-235.96M
Cash From (used in) Discontinued Operations--
Other Adjustments Net-161.7M-249.84M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-110.25M-117.98M
Acquisition Disposition of Subsidiaires-698.25M-48.58M
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities-51.45M242.9M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--6.94M
Issuance (Repayment) of Debt Securities455.7M-138.8M
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions-88.2M-69.4M
Other Cash from (used by) Financing Activities--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-36.75M-13.88M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year580.65M478.86M
Cash & Equivalents at Year End529.2M548.26M
All figures in USD. M: Millions of USD, B: Billions of USD.

ASPEN PHARMACR stock comparison chart provides an easy way to compare the stock price with peers along with details of ASPEN PHARMACR stock price history.
The statement of cash flows can be categorized into three main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that ASPEN PHARMACR is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - ASPEN PHARMACR stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $477.75M for APNHY.
  • Cash from investing stood at a negative value of $-859.95M for APNHY stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $367.5M for ASPEN PHARMACR.

Key Financial Ratios For ASPEN PHARMACR Cash Flow